Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Baird Downgrades Fastenal to Neutral, Announces $48 Price Target

Baird Downgrades Fastenal to Neutral, Announces $48 Price Target

Baird analyst David Manthey downgrades Fastenal (NASDAQ:FAST) from Outperform to Neutral and announces $48 price target.

byBenzinga Newsdesk

July 14, 2022

1 minute read

Baird analyst David Manthey downgrades Fastenal (NASDAQ:FAST) from Outperform to Neutral and announces $48 price target.

Analyst Ratings

Analyst Ratings for Tyra Biosciences

By Benzinga Insights

August 11, 11:00 AM

Within the last quarter, Tyra Biosciences (NASDAQ:TYRA) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…

TYRA

General
News

Goldman Sachs Contemplates Major Management Committee Overhaul: Report

By Benzinga Neuro

December 20, 7:50 AM

No final decision has been taken yet, and the final word rests with CEO David Solomon.

Stealth BioTherapeutics Enters Going Private Agreement

By Vandana Singh

August 1, 12:25 PM

Stealth BioTherapeutics Corp (NASDAQ:MITO) will be acquired by a consortium of investors led by Morningside Venture (I) Investments Ltd and J.…

MITO

AES’ Kuihelani Facility: Biggest Solar Plant In Hawaii Flips the Switch on Clean Energy

By Lekha Gupta

June 11, 1:48 PM

The AES Corporation's AES Hawaii launched the Kuihelani Solar-plus-Storage facility, generating 60MW of renewable energy and reducing Maui's reliance on fossil fuels.

AES

Baird Downgrades Fastenal to Neutral, Announces $48 Price Target

Related Posts

Analyst Ratings for Tyra Biosciences

Goldman Sachs Contemplates Major Management Committee Overhaul: Report

Stealth BioTherapeutics Enters Going Private Agreement

AES’ Kuihelani Facility: Biggest Solar Plant In Hawaii Flips the Switch on Clean Energy